- Active not recruitingPHASE1
Phase 1 Study of RP-6306 With Carboplatin and Paclitaxel in TP53 Ovarian and Uterine Cancer
This study looks at a new drug, RP-6306, combined with standard medicines (carboplatin and paclitaxel) for advanced ovarian or womb (uterine) cancer. We want to find the safest dose and see how well it works, especially for cancers with a specific gene change called TP53.
For: Recurrent Ovarian Cancer · Recurrent Uterine Cancer · Metastatic CancerCanada - RecruitingPHASE2
Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer
This study looks at new ways to treat advanced breast cancer that has stopped responding to standard treatments. By checking your blood or tumour for specific signs, doctors hope to find the best treatment for you, exploring several new drugs and combinations.
For: Breast CancerCanada